Alx Oncology Inc

We track 1 ClinicalTrials.gov studies led by Alx Oncology Inc. The portfolio skews toward Phase 2 (1 trials).

1 clinical trials sponsored by Alx Oncology Inc.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 1
100%

Trial Status Breakdown

Trials by Alx Oncology Inc

Protocol ASPEN-09-03: A Single-arm Phase 2 Multicenter Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Participants With Metastatic HER2-Positive Breast Cancer, a Substudy Under Master Protocol ASPEN-09: A Phase 1b/2, Multicenter, Multi Arm Study of Evorpacept in Combination With Anti-cancer Therapies in Advanced / Metastatic Malignancies

NCT07007559 · RECRUITING · Phase 2

Frequently Asked Questions

How many clinical trials does Alx Oncology Inc sponsor?

Alx Oncology Inc currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 2.

What conditions does Alx Oncology Inc research?

Alx Oncology Inc conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Alx Oncology Inc recruiting for clinical trials?

Yes, Alx Oncology Inc currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More